Ceftazidime Sodium + Sulbactam SodiumThird Party Manufacturing in India

Ceftazidime Sodium + Sulbactam Sodium works by combining a broad-spectrum, antipseudomonal third-generation cephalosporin with a beta-lactamase inhibitor. Ceftazidime sodium works by blocking bacterial cell wall synthesis. It binds selectively to critical penicillin-binding proteins, inhibiting the transpeptidation enzymes that form peptidoglycan cross-links. This disrupts the structural integrity of the bacterial cell wall, leading to cell lysis and death. Since many resistant gram-negative bacteria produce beta-lactamases that destroy ceftazidime, sulbactam sodium is added to the combination. Sulbactam acts as a suicide inhibitor, binding irreversibly to these beta-lactamases and neutralizing them. This action prevents the enzymatic degradation of ceftazidime, restoring and expanding its bactericidal activity against beta-lactamase-producing strains. The combination is highly effective against challenging gram-negative pathogens, including Pseudomonas aeruginosa, Acinetobacter species, and Enterobacteriaceae. It offers a crucial option in clinical settings where cephalosporin resistance is suspected. This combination is designed to preserve the clinical utility of ceftazidime, providing a reliable therapeutic option for serious, complicated infections.

Therapeutic Uses

Ceftazidime Sodium + Sulbactam Sodium is prescribed for the treatment of:

• Complicated Urinary Tract Infections: Treats severe pyelonephritis and urinary tract infections resistant to standard therapies.
• Intra-abdominal Infections: Indicated for complex polymicrobial infections, peritonitis, and biliary tract infections.
• Nosocomial Pneumonia: Used for hospital-acquired and ventilator-associated lower respiratory tract infections.
• Skin and Soft Tissue Infections: Treats diabetic foot infections and necrotizing fasciitis caused by resistant pathogens.
• Bone and Joint Infections: Effective against chronic osteomyelitis and septic arthritis.
• Febrile Neutropenia: Used as an empirical therapy in immunocompromised patients with suspected bacterial infections.

Why Manufacturers Choose Ceftazidime Sodium + Sulbactam Sodium

Ceftazidime Sodium + Sulbactam Sodium is a highly specialized hospital antibiotic combination. With the global rise of multidrug-resistant Gram-negative bacteria, this combination is a critical therapeutic option, driving strong demand from hospital procurement departments. For third party manufacturers in India, this combination represents a high-margin product that demands specialized sterile dry powder filling capabilities. The strict separation rules for cephalosporin manufacturing lines mean that only well-equipped WHO-GMP facilities can manufacture it. This makes Ceftazidime Sodium + Sulbactam Sodium one of the most sought-after molecules for third party manufacturing in India, with consistent demand from PCD franchise operators and export-oriented companies.